Jonathon Unwin
Stock Analyst at Barclays
(0.29)
# 4,514
Out of 5,022 analysts
66
Total ratings
34.3%
Success rate
-13.3%
Average return
Main Sectors:
Stocks Rated by Jonathon Unwin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: ONT Oxford Nanopore Technologies plc | Reiterated: Buy | 182p | 223p | -18.46% | 10 | Sep 28, 2026 | |
| SWX: YPSN Ypsomed Holding AG | Reiterated: Buy | CHF 480.00 | CHF 357.80 | +34.15% | 9 | Sep 24, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Upgraded: Buy | €16.00 → €27.00 | €24.50 | +10.20% | 13 | Aug 18, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Reiterated: Hold | €28.00 → €27.00 | €31.30 | -13.74% | 11 | Aug 11, 2026 | |
| ETR: GXI Gerresheimer AG | Reiterated: Sell | €17.00 → €25.00 | €27.52 | -9.16% | 9 | Jul 29, 2026 | |
| STO: VIMIAN Vimian Group AB (publ) | Reiterated: Sell | kr 26.00 → kr 29.00 | kr 35.20 | -17.61% | 14 | Jul 23, 2026 |
Oxford Nanopore Technologies plc
Sep 28, 2026
Reiterated: Buy
Price Target: 182p
Current: 223p
Upside: -18.46%
Ypsomed Holding AG
Sep 24, 2026
Reiterated: Buy
Price Target: CHF 480.00
Current: CHF 357.80
Upside: +34.15%
SCHOTT Pharma AG & Co. KGaA
Aug 18, 2026
Upgraded: Buy
Price Target: €16.00 → €27.00
Current: €24.50
Upside: +10.20%
Carl Zeiss Meditec AG
Aug 11, 2026
Reiterated: Hold
Price Target: €28.00 → €27.00
Current: €31.30
Upside: -13.74%
Gerresheimer AG
Jul 29, 2026
Reiterated: Sell
Price Target: €17.00 → €25.00
Current: €27.52
Upside: -9.16%
Vimian Group AB (publ)
Jul 23, 2026
Reiterated: Sell
Price Target: kr 26.00 → kr 29.00
Current: kr 35.20
Upside: -17.61%